Pre-existing antibodies targeting a dominant linear antibody epitope on SARS-CoV-2 S2 cross-reacted with commensal gut bacteria and shaped immune responses elicited by a candidate vaccine
Liqiu Jia, Shufeng Weng, View ORCID ProfileJing Wu, Xiangxiang Tian, Yifan Zhang, Xuyang Wang, Jing Wang, Dongmei Yan, Wanhai Wang, Zhaoqin Zhu, Chao Qiu, Wenhong Zhang, Ying Xu, View ORCID ProfileYanmin Wan
doi: https://doi.org/10.1101/2021.07.13.21260404
Liqiu Jia
1Department of Infectious Diseases, National Medical Center for Infectious Diseases, Shanghai Key Laboratory of Infectious Diseases and Biosafety Emergency Response, Huashan Hospital, Shanghai Medical College, Fudan University, Shanghai, China
Shufeng Weng
2State Key Laboratory of Genetic Engineering, Institute of Genetics, School of Life Science, Fudan University, Shanghai, China
Jing Wu
1Department of Infectious Diseases, National Medical Center for Infectious Diseases, Shanghai Key Laboratory of Infectious Diseases and Biosafety Emergency Response, Huashan Hospital, Shanghai Medical College, Fudan University, Shanghai, China
Xiangxiang Tian
3Department of laboratory medicine, Shanghai Public Health Clinical Center, Shanghai, China
4Clinical Laboratory, The First Affiliated Hospital of Zhengzhou University, Key Laboratory of Laboratory Medicine of Henan Province, Zhengzhou, Henan, P.R. China
Yifan Zhang
3Department of laboratory medicine, Shanghai Public Health Clinical Center, Shanghai, China
4Clinical Laboratory, The First Affiliated Hospital of Zhengzhou University, Key Laboratory of Laboratory Medicine of Henan Province, Zhengzhou, Henan, P.R. China
Xuyang Wang
1Department of Infectious Diseases, National Medical Center for Infectious Diseases, Shanghai Key Laboratory of Infectious Diseases and Biosafety Emergency Response, Huashan Hospital, Shanghai Medical College, Fudan University, Shanghai, China
Jing Wang
3Department of laboratory medicine, Shanghai Public Health Clinical Center, Shanghai, China
5Department of Immunology, School of Basic Medical, Jiamusi University, Jiamusi, Heilongjiang Province, China
Dongmei Yan
5Department of Immunology, School of Basic Medical, Jiamusi University, Jiamusi, Heilongjiang Province, China
Wanhai Wang
4Clinical Laboratory, The First Affiliated Hospital of Zhengzhou University, Key Laboratory of Laboratory Medicine of Henan Province, Zhengzhou, Henan, P.R. China
Zhaoqin Zhu
3Department of laboratory medicine, Shanghai Public Health Clinical Center, Shanghai, China
Chao Qiu
6Institutes of biomedical sciences & Shanghai Key Laboratory of Medical Epigenetics, Fudan University, Shanghai, China
Wenhong Zhang
1Department of Infectious Diseases, National Medical Center for Infectious Diseases, Shanghai Key Laboratory of Infectious Diseases and Biosafety Emergency Response, Huashan Hospital, Shanghai Medical College, Fudan University, Shanghai, China
2State Key Laboratory of Genetic Engineering, Institute of Genetics, School of Life Science, Fudan University, Shanghai, China
7National Clinical Research Center for Aging and Medicine, Huashan Hospital, Shanghai Medical College, Fudan University, Shanghai, China
8Key Laboratory of Medical Molecular Virology (MOE/MOH) and Institutes of Biomedical Sciences, Shanghai Medical College, Fudan University, Shanghai, China
Ying Xu
2State Key Laboratory of Genetic Engineering, Institute of Genetics, School of Life Science, Fudan University, Shanghai, China
Yanmin Wan
1Department of Infectious Diseases, National Medical Center for Infectious Diseases, Shanghai Key Laboratory of Infectious Diseases and Biosafety Emergency Response, Huashan Hospital, Shanghai Medical College, Fudan University, Shanghai, China
2State Key Laboratory of Genetic Engineering, Institute of Genetics, School of Life Science, Fudan University, Shanghai, China
9Department of radiology, Shanghai Public Health Clinical Center, Shanghai, China
Posted July 15, 2021.
Pre-existing antibodies targeting a dominant linear antibody epitope on SARS-CoV-2 S2 cross-reacted with commensal gut bacteria and shaped immune responses elicited by a candidate vaccine
Liqiu Jia, Shufeng Weng, Jing Wu, Xiangxiang Tian, Yifan Zhang, Xuyang Wang, Jing Wang, Dongmei Yan, Wanhai Wang, Zhaoqin Zhu, Chao Qiu, Wenhong Zhang, Ying Xu, Yanmin Wan
medRxiv 2021.07.13.21260404; doi: https://doi.org/10.1101/2021.07.13.21260404
Pre-existing antibodies targeting a dominant linear antibody epitope on SARS-CoV-2 S2 cross-reacted with commensal gut bacteria and shaped immune responses elicited by a candidate vaccine
Liqiu Jia, Shufeng Weng, Jing Wu, Xiangxiang Tian, Yifan Zhang, Xuyang Wang, Jing Wang, Dongmei Yan, Wanhai Wang, Zhaoqin Zhu, Chao Qiu, Wenhong Zhang, Ying Xu, Yanmin Wan
medRxiv 2021.07.13.21260404; doi: https://doi.org/10.1101/2021.07.13.21260404
Subject Area
Subject Areas
- Addiction Medicine (370)
- Allergy and Immunology (689)
- Anesthesia (184)
- Cardiovascular Medicine (2748)
- Dermatology (235)
- Emergency Medicine (414)
- Epidemiology (12398)
- Forensic Medicine (10)
- Gastroenterology (784)
- Genetic and Genomic Medicine (4259)
- Geriatric Medicine (396)
- Health Economics (699)
- Health Informatics (2757)
- Health Policy (1018)
- Hematology (369)
- HIV/AIDS (879)
- Medical Education (404)
- Medical Ethics (112)
- Nephrology (453)
- Neurology (4036)
- Nursing (216)
- Nutrition (598)
- Oncology (2126)
- Ophthalmology (604)
- Orthopedics (251)
- Otolaryngology (312)
- Pain Medicine (256)
- Palliative Medicine (77)
- Pathology (478)
- Pediatrics (1148)
- Primary Care Research (468)
- Public and Global Health (6652)
- Radiology and Imaging (1446)
- Respiratory Medicine (886)
- Rheumatology (421)
- Sports Medicine (353)
- Surgery (464)
- Toxicology (57)
- Transplantation (192)
- Urology (171)